1 |
Florenzano P, Cipriani C, Roszko KL, et al. Approach to patients with hypophosphataemia [J]. Lancet Diabetes Endocrinol, 2020, 8(2) : 163-174.
|
2 |
Leung J, Crook M. Disorders of phosphate metabolism [J]. J Clin Pathol, 2019, 72(11) : 741-747.
|
3 |
Hoffmann M, Zemlin AE, Meyer WP, et al. Hypophosphataemia at a large academic hospital in South Africa [J]. J Clin Pathol, 2008, 61(10) : 1104-1107.
|
4 |
Sun Z, Ye H, Shen X, et al. Continuous venovenous hemofiltration versus extended daily hemofiltration in patients with septic acute kidney injury: a retrospective cohort study [J]. Crit Care, 2014, 18(2) : R70.
|
5 |
Demirjian S, Teo BW, Guzman JA, et al. Hypophosphatemia during continuous hemodialysis is associated with prolonged respiratory failure in patients with acute kidney injury [J]. Nephrol Dial Transplant, 2011, 26(11) : 3508-3514.
|
6 |
Yang Y, Zhang P, Cui Y, et al. Hypophosphatemia during continuous veno-venous hemofiltration is associated with mortality in critically ill patients with acute kidney injury [J]. Crit Care, 2013, 17(5) : R205.
|
7 |
Bellomo R, Cass A, Cole L, et al. The relationship between hypophosphataemia and outcomes during low-intensity and high-intensity continuous renal replacement therapy [J]. Crit Care Resusc, 2014, 16(1) : 34-41.
|
8 |
Hendrix RJ, Hastings MC, Samarin M, et al. Predictors of hypophosphatemia and outcomes during continuous renal replacement therapy [J]. Blood Purif, 2020, 49(6) : 700-707.
|
9 |
Pistolesi V, Zeppilli L, Fiaccadori E, et al. Hypophosphatemia in critically ill patients with acute kidney injury on renal replacement therapies [J]. J Nephrol, 2019, 32(6) : 895-908.
|
10 |
Heung M, Mueller BA. Prevention of hypophosphatemia during continuous renal replacement therapy-an overlooked problem [J]. Semin Dial, 2018, 31(3) : 213-218.
|
11 |
Glendenning P, Bell DA, Clifton-Bligh RJ. Investigating hypophosphataemia [J]. BMJ, 2014, 348: g3172.
|
12 |
Santiago MJ, López-Herce J, Urbano J, et al. Hypophosphatemia and phosphate supplementation during continuous renal replacement therapy in children [J]. Kidney Int, 2009, 75(3) : 312-316.
|
13 |
Broman M, Carlsson O, Friberg H, et al. Phosphate-containing dialysis solution prevents hypophosphatemia during continuous renal replacement therapy [J]. Acta Anaesthesiol Scand, 2011, 55(1) : 39-45.
|
14 |
Ricci Z, Ronco C. Dialysis: preventing hypophosphatemia during pediatric CRRT [J]. Nat Rev Nephrol, 2009, 5(5) : 251-252.
|
15 |
Bellomo R, Baldwin I, Ronco C, et al. ICU-based renal replacement therapy [J]. Crit Care Med, 2021, 49(3) : 406-418.
|
16 |
Song YH, Seo EH, Yoo YS, et al. Phosphate supplementation for hypophosphatemia during continuous renal replacement therapy in adults [J]. Renal Failure, 2019, 41(1) : 72-79.
|
17 |
Zhang D, Maalouf NM, Adams-Huet B, et al. Effects of sex and postmenopausal estrogen use on serum phosphorus levels: a cross-sectional study of the National Health and Nutrition Examination Survey (NHANES) 2003-2006 [J]. Am J Kidney Dis, 2014, 63(2) : 198-205.
|
18 |
Lim C, Tan HK, Kaushik M. Hypophosphatemia in critically ill patients with acute kidney injury treated with hemodialysis is associated with adverse events [J]. Clin Kidney J, 2017, 10(3) : 341-347.
|
19 |
RENAL Replacement Therapy Study Investigators; Bellomo R, Cass A, Cole L, et al. Intensity of continuous renal-replacement therapy in critically ill patients [J]. N Engl J Med, 2009, 361(17) : 1627-1638.
|
20 |
Thompson Bastin ML, Adams PM, Nerusu S, et al. Association of phosphate containing solutions with incident hypophosphatemia in critically ill patients requiring continuous renal replacement therapy [J]. Blood Purif, 2021, 51(2): 122-129.
|
21 |
Busch RA, Curtis CS, Kight CE, et al. An institutional change in continuous renal replacement therapy [J]. Nutr Clin Pract, 2016, 32(2): 245-251.
|
22 |
Thongprayoon C, Radhakrishnan Y, Cheungpasitporn W, et al. Association of serum phosphate derangement with mortality in patients on continuous renal replacement therapy [J]. Can J Kidney Health Dis, 2022, 9: 20543581221114697.
|
23 |
Godaly G, Carlsson O, Broman M. Phoxilium(R) reduces hypophosphataemia and magnesium supplementation during continuous renal replacement therapy [J]. Clin Kidney J, 2016, 9(2): 205-10.
|
24 |
Shaw AR, Chaijamorn W, Clark JS, et al. Preparation times and costs for various solutions used for continuous renal replacement therapy [J]. Am J Health Syst Pharm, 2018, 75(11): 808-815.
|
25 |
Cho A, Lee YK, and Park HC, Impact of electrolyte-rich dialysate during continuous renal replacement therapy on serum phosphate and potassium in ICU patients [J]. PLoS One, 2020, 15(9): e0238867.
|
26 |
Nalesso F, Garzotto F, Cattarin L, et al. Impact of different hemodiafiltration solutions on ionemia in long-term CRRT [J]. Int J Artif Organs, 2021, 44(11): 807-815.
|
27 |
Baeg SI, Jeon J, Kang D, et al. Impact of protocolized fluid management on electrolyte stability in patients undergoing continuous renal replacement therapy [J]. Front Med (Lausanne), 2022, 9: 915072.
|